12 hrs ago | The Papillion Times
J&J gets FDA warning about handling of complaints
Former Husker Alfonzo Dennard, charged with third-degree assault of a police officer, has entered a written plea of not guilty and waived Wednesday's arraignment hearing, according to court documents.
12 hrs ago | The Miami Herald
J&J gets FDA warning about handling of complaints
The Food and Drug Administration is warning a Johnson & Johnson unit that it failed to look into dozens of consumer complaints about its K-Y Liquibeads Vaginal Moisturizer and other products in the last two years.
14 hrs ago | Eyefortransport
Exploring Logistics in the Developing Markets of China, India and Vietnam.
Mark Millar, who will be moderating two sessions at the upcoming 3PL Summit, discusses the challenges and opportunities in emerging and developing logistics markets.
Is Responsive Design Just Another Hype?
The multiplatform digital world can be daunting for brands. There are many ways to reach consumers online, each requiring different versions of content.
Us Fda warns J&J unit about tampon complaints
French farmers who force-feed their ducks to produce foie gras for the luxury food market, are turning their attention to alternative fuels, using excess duck fat to run deisel vehicles.
Mergers a "key problem" for regulatory compliance, drug quality expert says
Biopharma mergers are a " key problem " for manufacturing quality teams as the loss of focus can lead to regulatory actions, a compliance expert said.
Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer
BOSTON -- This week's Biotech Stock Mailbag focuses on two big topics, the upcoming ASCO cancer meeting and Celldex Therapeutics I also take a rare detour from biotech stocks to write about Zafgen , a privately held obesity drug company.
Saskatoon gardener looking for couple after finding wedding band
A discovery in a Saskatoon garden suggests there may be a couple approaching a marriage milestone - without an important piece of jewelry.
U.S. advisers reject new use for J&J/Bayer's Xarelto
U.S. advisers recommended against expanding the use of Johnson & Johnson's blood thinner Xarelto as a way to reduce the risk of new heart attacks and strokes in people with heart problems.
FDA panel votes against new use for J&J's Xarelto
Martha Stewart, on Wednesday, was named as non-executive chairman of the lifestyle, media and merchandising company that she created.
UPDATE 1-US advisers reject new use for J&J/Bayer's Xarelto
U.S. advisers recommended against expanding the use of Johnson & Johnson's blood thinner Xarelto as a way to reduce the risk of new heart attacks and strokes in people with heart problems.
PhillyPharma: Johnson & Johnson's Xarelto FDA advisory hearing Wednesday to discuss trial dropouts
The U.S. Food and Drug Administration's cardiovascular and renal drugs advisory committee will meet Wednesday to review whether the drug, rivaroxaban should be approved as a blood thinner to help patients with heart disease avoid blood clots, which can cause heart attacks and strokes.
J&J's Simponi Helps Colitis Patients In Clinical Trial
Johnson & Johnson said its drug Simponi improved symptoms in a majority of patients with an inflammatory-bowel disease in a new clinical trial.
Missing data raise doubts on J&J drug-Us Fda staff
U.S. drug reviewers said missing data for Johnson & Johnson's blood thinner Xarelto raised doubts about whether the drug actually reduced the risk of new heart attacks and strokes in people with heart problems.
Update 1-Missing data raise doubts on J&J drug-Us Fda staff
U.S. drug reviewers said missing data for Johnson & Johnson's blood thinner Xarelto raised doubts about whether the drug actually reduced the risk of new heart attacks and strokes in people with heart problems.
The proliferation of digital media devices is leading some designers to move toward responsive designs of their properties that morph based on how the content is accessed.
J&J wins first dispute of its kind in China
Johnson & Johnson has won the first-ever monopolistic dispute between a producer and dealer on the Chinese mainland, with the court rejecting the dealer's compensation request of 14 million yuan , said Shanghai No.1 Intermediate People's Court.
J&J Actively Pursuing M&A In China
For the first time, a Partnering Bootcamp has been added to the annual ChinaBio Partnering Forum.
Dendreon stock dives after rival's cancer drug shows benefits
The stock of Dendreon, maker of the prostate-cancer drug Provenge, dropped to its lowest value in four months after a study showed that Johnson & Johnson's rival medicine Zytiga helped high-risk patients.
OraSure Rises as At-Home HIV Test Moves Closer to FDA Approval
OraSure Technologies Inc. soared the most in three years after U.S. regulatory advisers backed its bid to bring to market the first at-home HIV test that lets people get results without using a doctor or laboratory.